Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
NuCana plc
Jiangsu Cancer Institute & Hospital
Jiangsu Cancer Institute & Hospital
Belgian Gynaecological Oncology Group
University College, London
AGO Study Group